Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2021

Feb 15, 2022

SELL
$2.13 - $3.46 $2,193 - $3,563
-1,030 Closed
0 $0
Q3 2021

Nov 15, 2021

BUY
$3.14 - $3.9 $361 - $448
115 Added 12.57%
1,030 $3,000
Q2 2021

Aug 12, 2021

BUY
$3.8 - $4.56 $228 - $273
60 Added 7.02%
915 $3,000
Q1 2021

May 13, 2021

BUY
$4.33 - $6.63 $433 - $663
100 Added 13.25%
855 $3,000
Q4 2020

Feb 12, 2021

BUY
$4.87 - $17.29 $2,313 - $8,212
475 Added 169.64%
755 $4,000
Q3 2020

Nov 13, 2020

BUY
$15.08 - $27.04 $4,222 - $7,571
280 New
280 $4,000

Others Institutions Holding ASMB

# of Institutions
1
Shares Held
16.3K
Call Options Held
0
Put Options Held
0

About ASSEMBLY BIOSCIENCES, INC.


  • Ticker ASMB
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 48,436,900
  • Market Cap $737M
  • Description
  • Assembly Biosciences, Inc., a clinical-stage biotechnology company, discovers and develops therapeutic candidates for the treatment of hepatitis B virus (HBV) infection in the United States. The company's lead product candidate is Vebicorvir, which as completed Phase 2 clinical trials to treat patients with chronic HBV infection. It is also deve...
More about ASMB
Track This Portfolio

Track Penserra Capital Management LLC Portfolio

Follow Penserra Capital Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Penserra Capital Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Penserra Capital Management LLC with notifications on news.